Texas HHS uses Acentra Health for DUR intervention
Trusted by teams at
Description
The Texas Department of Health and Human Services utilized Acentra Health to conduct a retrospective drug utilization review on anticonvulsant interactions for Medicaid members, including analytics via the RxExplorer application and prescriber intervention mailings. The engagement supported population-based DUR letters and post-intervention outcome and cost-savings analysis over defined pre- and post-periods.
Contract Details
Vendor
ACENTRA HEALTH
Agency
Texas Health and Human Services, TX
Contract Type
PROFESSIONAL_SERVICES
Document Date
February 1, 2026
Contract Term
Intervention process executed June 23, 2025 – January 12, 2026 (pre- and post-intervention evaluation periods defined in report)
Renewal Info
Underlying contract appears to cover DUR analytics and intervention mailings; specific renewal terms are not described in the report.
More from ACENTRA HEALTH
More from Texas Health and Human Services
Texas Health and Human Services Interagency Contracts with Institutions of Higher Education Report 2026-05-21
Texas Health and Human Services Interagency Contracts with Institutions of Higher Education Report 2026-05-21
Texas Health and Human Services Interagency Contracts with Institutions of Higher Education Report 2026-05-21
Texas Health and Human Services Interagency Contracts with Institutions of Higher Education Report 2026-05-21
Texas Health and Human Services Interagency Contracts with Institutions of Higher Education Report 2026-05-21
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.